Results 161 to 170 of about 158,092 (291)

Downstream Treatment Burden and Health‐Care Utilization Following Initiation of GLP‐1 Receptor Agonists or SGLT2 Inhibitors in Type 2 Diabetes

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and sodium–glucose cotransporter 2 (SGLT2) inhibitors are widely used for the treatment of type 2 diabetes, yet their downstream consequences in routine clinical practice remain incompletely characterized.
Yazan Alhamdan, Jason C. Hsu, Christine Y. Lu   +2 more
wiley   +1 more source

A Case of a 31-Year-Old Female Patient With Systemic Lupus Erythematosus Presenting With Lupus-Associated Pleural Effusions and Newly Diagnosed Lupus Nephritis. [PDF]

Cureus
Nanneboyina KS, Avila J.
europepmc   +1 more source

Glomerular plasmalemma vesicle‐associated protein‐1 as an endothelial remodelling marker complementing C4d in chronic active antibody‐mediated rejection

Histopathology, EarlyView.
Glomerular plasmalemma vesicle‐associated protein‐1 (PV‐1/PLVAP) identifies dynamic endothelial remodelling in chronic active antibody‐mediated rejection (caABMR), complementing glomerular C4d, which reflects a static footprint of complement activation. Combined assessment of PV‐1 and C4d captures complementary dimensions of microvascular pathology and
Yuto Igarashi, Mayu Shimokawa, Kunio Kawanishi, Toshihito Hirai, Hiroshi Seino, Tomokazu Shimizu, Hideki Ishida, Toshio Takagi   +7 more
wiley   +1 more source

Sexual dimorphism of early GPR183-dependent B cell responses in systemic lupus erythematosus. [PDF]

iScience
Matei DE, de Gruijter NM, Jenkins P, Radziszewska A, Peckham H, Jebson B, Karu K, Ciurtin C, Rosser EC.   +8 more
europepmc   +1 more source

LIGHT AND ELECTRON MICROSCOPIC STUDY OF BIOPSIES FROM THIRTY‐THREE HUMAN RENAL ALLOGRAFTS AND AN ISOGRAFT 1³/4–2¹/2 YEARS AFTER TRANSPLANTATION [PDF]

, 1966
ALLEN, BROWNE, CALNE, FELDMAN, GALLE, HAMBURGER, HAMBURGER, HEDLEY-WHYTE, HILL, KRIEG, MERRILL, MOVAT, MOVAT, NEUSTEIN, OGILVIE, PFEIFFER, PORTER, PORTER, PORTER, PORTER, RIFKIND, SHIBAGAKI, STARZL, STARZL, TERASAKI, TERASAKI, WOODRUFF, ZUKOSKI   +27 more
core   +1 more source

SYPHILITIC NEPHRITIS [PDF]

BMJ, 1925
openaire   +2 more sources

Single-center experience of voclosporin use for pediatric lupus nephritis: a case series. [PDF]

Rheumatology (Oxford)
Hazan R, Tang Civilibal N, Baszis K, Bigley TM.   +3 more
europepmc   +1 more source

Evolving treatments for Sjögren disease: current approaches and emerging targets

Internal Medicine Journal, EarlyView.
Abstract Sjögren disease (SjD) is a prevalent systemic autoimmune condition characterised by exocrine gland dysfunction, systemic inflammation and heterogeneous organ involvement. Current management remains largely symptomatic, with no approved disease‐modifying therapies available and substantial unmet clinical need. However, advances in understanding
Mansi Bhurani, Adrian Y. S. Lee, Maureen Rischmueller, Alberta Hoi   +3 more
wiley   +1 more source

Correction: Endothelial cells regulate mesangial cells through the Dll4/Notch3 axis to participate in glomerular injury in lupus nephritis. [PDF]

Front Immunol
Guo H, Mao Y, Wang Y, Yu B, Gu Z, Yao C, Da Z.   +6 more
europepmc   +1 more source

Practical recommendations for treating patients with chronic kidney disease in Australia: a multidisciplinary approach

Internal Medicine Journal, EarlyView.
Abstract Background Chronic kidney disease (CKD) is a significant public health challenge in Australia, affecting ~10% of the adult population and contributing to substantial morbidity and mortality. Diabetes, hypertension, cardiovascular disease and CKD frequently co‐exist; therefore, a multidisciplinary approach is necessary to manage these ...
M. P. Schlaich, W. P. Abhayaratna, R. Audehm, E. I. Ekinci, R. J. MacIsaac, A. J. Nelson, A. Sharma, C. Pollock   +7 more
wiley   +1 more source